Mahatinib

N/A

Report date: 2026/03/21 20:00:21
NME

Base Information

Drug NameMahatinib
Drug Alias Name(R)-9bMS(R)-9b
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOligodendrocyte transcription factor 2 inhibitors
TargetsOligodendrocyte transcription factor 2
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTechnoGenesys Inc
China Registration ClassN/A

Develop Information

Active CompaniesTechnoGenesys Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A